Premium
CD36 immunization in a patient undergoing hematopoietic stem cell transplantation
Author(s) -
Culler Elizabeth E.,
Hillyer Christopher D.,
Haight Ann E.,
Castillejo MartaInés,
Josephson Cassandra D.
Publication year - 2008
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.21180
Subject(s) - medicine , apheresis , hematopoietic stem cell transplantation , immunology , human leukocyte antigen , antibody , cd36 , transplantation , platelet , hematopoietic stem cell , stem cell , antigen , platelet transfusion , haematopoiesis , biology , receptor , genetics
Anti‐CD36 antibodies are known to cause a platelet refractory state. We describe a previously unreported case of a 16‐year‐old female sickle cell disease patient with anti‐CD36 antibodies, detected on routine screen prior to hematopoietic stem cell transplantation (HSCT). CD36 platelet antigen typing was negative for both the patient and her HLA‐identical donor sibling. Patient plasma was compatible with 48 of 49 apheresis platelets, which were untested and presumably positive for the CD36 antigen. The patient responded adequately to transfusion of crossmatch compatible platelets and successfully underwent HSCT. The presence of anti‐CD36 antibodies does not exclude potential candidates from HSCT. Pediatr Blood Cancer 2008;50:660–662. © 2007 Wiley‐Liss, Inc.